Catheter Precision Inc (VTAK)
0.422
0.00 (0.00%)
USD |
NYAM |
Nov 22, 16:00
0.4146
-0.01
(-1.75%)
After-Hours: 20:00
Catheter Precision Cash from Operations (Quarterly): -2.768M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -2.768M |
June 30, 2024 | -1.697M |
March 31, 2024 | -1.942M |
December 31, 2023 | -1.889M |
September 30, 2023 | -1.83M |
June 30, 2023 | -4.847M |
March 31, 2023 | -12.05M |
December 31, 2022 | -3.025M |
September 30, 2022 | -4.966M |
June 30, 2022 | -6.008M |
March 31, 2022 | -8.569M |
December 31, 2021 | -5.711M |
September 30, 2021 | -7.215M |
June 30, 2021 | -6.621M |
March 31, 2021 | -8.078M |
December 31, 2020 | -9.414M |
Date | Value |
---|---|
September 30, 2020 | -6.047M |
June 30, 2020 | -5.80M |
March 31, 2020 | -7.043M |
December 31, 2019 | -9.572M |
September 30, 2019 | -7.854M |
June 30, 2019 | -6.803M |
March 31, 2019 | -8.944M |
December 31, 2018 | -8.399M |
September 30, 2018 | -4.143M |
June 30, 2018 | -3.541M |
March 31, 2018 | -2.425M |
December 31, 2017 | -1.505M |
September 30, 2017 | -1.247M |
June 30, 2017 | -1.072M |
March 31, 2017 | -1.699M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-12.05M
Minimum
Mar 2023
-1.697M
Maximum
Jun 2024
-5.755M
Average
-5.904M
Median
Cash from Operations (Quarterly) Benchmarks
Plus Therapeutics Inc | -3.68M |
Perspective Therapeutics Inc | 3.366M |
Retractable Technologies Inc | -5.727M |
InfuSystems Holdings Inc | 9.842M |
Xtant Medical Holdings Inc | -1.718M |
Cash from Operations (Quarterly) Related Metrics
Cash from Financing (Quarterly) | 4.02M |
Free Cash Flow | -8.381M |
Free Cash Flow Per Share (Quarterly) | -1.350 |
Free Cash Flow to Equity (Quarterly) | -3.867M |
Free Cash Flow Yield | -1.87K% |